Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - FDA-2010-N-0254

# AGENCY:

 Food and Drug Administration, HHS.

# ACTION:

Notice of meeting.

# SUMMARY:

 The Food and Drug Administration (FDA) is announcing a public meeting entitled “International Cooperation on Cosmetic Regulations (ICCR)—Preparation for ICCR-4 Meetings in Toronto, Canada” to provide information and receive comments on the ICCR as well as the upcoming meetings in Toronto, Canada. The topics to be discussed are the topics for discussion at the forthcoming ICCR Steering Committee meeting. The purpose of the meeting is to solicit public input prior to the next Steering Committee and expert working group meetings in Toronto, Canada the week of July 12, 2010.

*Date and Time*: The meeting will be held on Wednesday, July 7, 2010, from 1:30 p.m. to 3:30 p.m.                    

*Location*: The meeting will be held in the Washington Theater at the Hilton Washington DC/Rockville Hotel & Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person*: All participants must register with Jennifer Haggerty, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, rm. 3567, Silver Spring, MD 20903, 301-796-4600. Register by emailing:                         *jennifer.haggerty@fda.hhs.gov.*

*Registration and Requests for Oral Presentations*: Send registration information (including name, title, firm name, address, telephone, and fax number), written material and requests to make oral presentation, to the contact person by July 2, 2010.                    

                        If you need special accommodations due to a disability, please contact Jennifer Haggerty (see                         *Contact Person*) at least 7 days in advance.                    

*Transcripts*: Please be advised that as soon as a transcript is available, it will be accessible at                         *http://www.regulations.gov*. It may be viewed at the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A transcript will also be available in either hardcopy or on CD-ROM, after submission of a Freedom of Information request. Written requests are to be sent to Division of Freedom of Information (HFI-35), Office of Management Programs, Food and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD 20857.                    

# SUPPLEMENTARY INFORMATION:

The purpose of the multilateral framework on the ICCR is to pave the way for the removal of regulatory obstacles to international trade while maintaining global consumer protection.

ICCR is a voluntary international group of cosmetics regulatory authorities from the United States, Japan, the European Union, and Canada. These regulatory authority members will enter into constructive dialogue with their relevant cosmetics' industry trade associations. Currently, the ICCR members are Health Canada; the European Directorate General for Enterprise and Industry; the Ministry of Health, Labor and Welfare of Japan; and the U.S. Food and Drug Administration. All decisions made by the consensus will be compatible with the laws, policies, rules, regulations, and directives of the respective administrations and governments. Members will implement and/or promote actions or documents within their own jurisdictions and seek convergence of regulatory policies and practices. Successful implementation will require input from stakeholders.

Interested persons may present data, information, or views orally or in writing, on issues pending at the public meeting. Time allotted for oral presentations may be limited to 10 minutes. Those desiring to make oral presentations should notify the contact person by July 2, 2010, and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses, telephone number, fax, and e-mail of proposed participants, and an indication of the approximate time requested to make their presentation.

                    The agenda for the public meeting will be made available on the Internet at:                     *http://www.fda.gov/​Cosmetics/​InternationalActivities/​ConferencesMeetingsWorkshops.*

Dated: June 4, 2010.

Leslie Kux,

Acting Assistant Commissioner for Policy.

[FR Doc. 2010-13821 Filed 6-8-10; 8:45 am]

BILLING CODE 4160-01-S